Literatur
-
1
Alberini J L, Belhocine T, Hustinx R. et al .
Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumours (CUP syndrome).
Nucl Med Commun.
2003;
24
1081-1086
-
2
Bouffet E, Doumi N, Thiesse P. et al .
Brain metastases in children with solid tumors.
Cancer.
1997;
79
403-410
-
3
Coia L R, Aaronson N, Linggood R. et al .
A report of the consensus workshop panel on the treatment of brain metastases.
Int J Radiat Oncol Biol Phys.
1992;
23
223-227
-
4
Delattre J Y, Krol G, Thaler H T, Posner J B.
Distribution of brain metastases.
Arch Neurol.
1988;
45
741-744
-
5 Deutsche Gesellschaft für Neurologie .Leitlinie Hirnmetastasen;. www.dgn.org/81.0.html
-
6
Engenhart R, Kimmig B N, Hover K. et al .
Long-term follow up for brain metastases treated by percutaneous single high dose radiation.
Cancer.
1993;
71
1353-1361
-
7
Epstein B E, Scott C B, Sause W T. et al .
Improved survival duration in patients with unsresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54,4 Gy and greater.
Cancer.
1993;
71
1362-1367
-
8
Gross M, Klauss H, Engenhart R.
Strahlentherapeutisches Management von Hirnmetastasen.
Onkologe.
2000;
6
948-958
-
9
Grosu A, Feldmann H J, Stärk S. et al .
Stereotaktische Strahlentherapie am adaptierten Linearbeschleuniger bei Patienten mit Hirnmetastasen.
Der Nervenarzt.
2001;
72
770-781
-
10
Jereczyk-Fossa B A, Jassem J, Orecchia R.
Cervical lymph node metastases of squamous cell carcinoma from an unknown primary.
Cancer Treat Rev.
2004;
30
153-164
-
11
Johnson J D, Young B.
Demographics of brain metastasis.
Neurosurg Clin N Am.
1996;
7
337
-
12
Knoop M, Sola S, Hebecker R. et al .
Seltene pulmonalen Manifestation eines intrakraniellen meningothelialen Meningeoms.
Dtsch Med Wochenschr.
2004;
129
1854-1857
-
13
Kondziola D, Patel A, Lundsford L D. et al .
Stereotactic radiosurgery plus brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases.
Int J Radiat Oncol Biol Phys.
1999;
45
427-434
-
14
Korfol A, Thiel E.
Chemotherapie zerebraler Metastasen solider Tumoren.
Onkologe.
2000;
6
959-965
-
15
Lagerwaard F J, Levendag P C, Nowak P J. et al .
Identification of prognostic factors in patients with brain metastases: a review of 1292 patients.
Int J Radiat Oncol Biol Phys.
1999;
43
795-804
-
16
Mehta M P, Rozental J M, Levin A B. et al .
Defining the role of stereotactic radiosurgery in the management of brain metastases.
Int J Radiat Oncol Biol Phys.
1992;
24
619-625
-
17
Patchell R A, Tibbs P A, Walsh J W. et al .
A randomised trial of surgery in the treatment of single metastases to the brain.
N Engl J Med.
1990;
322
494-500
-
18
Pickren J W, Lopez G, Tsukada Y, Lane W W.
Brain metastases: An autopsy study.
Cancer Treat Sym.
1983;
2
295-313
-
19
Regine W F, Mohiuddin M, Tibbs P A. et al .
A randomised prospective trial of the benefit of postoperative radiotherapy in the treatment of single metastases to the brain.
Int J Radiat Oncol Biol Phys.
1998;
42
1996
-
20
Schackert G, Steinmetz A, Sobottka S.
Neurochirurgische Therapie der Hirnmetastasen.
Onkologe.
2000;
6
939-947
-
21
Schmid U D, Honegger H P, Pescia R.
Chirurgie der Hirnmetastasen.
Schweiz Med Forum.
2002;
50
1187-1194
-
22
Shaw E G, Scott C, Souhami L. et al .
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90 - 05.
Int J Radiat Oncol Biol Phys.
2000;
47
291-298
-
23
Varadhacary G R, Abbruzzese J L, Lenzi R.
Diagnostic strategies for for unknown primary cancer.
Cancer.
2004;
100
1776-1785
-
24
Vecht C J, Haaxma-Reiche H, Noordijk E M. et al .
Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?.
Ann Neurol.
1993;
33
583-590
-
25
Vecht C J, Hovestadt A, Verbiest H B. et al .
Dose-effect relationship of dexametasone on Karnofsky performance in metastatic brain tumors: a randomised study of doses 4, 8, and 16 mg per day.
Neurology.
1994;
44
675-680
-
26
Wen P Y, Loeffler J S.
Management of brain metastases.
Oncology.
1999;
13
941-954
Dr. med. F. Gundling
II. Medizinische Abteilung für Gastroenterologie, Hepatologie und Gastroenterologische Onkologie, Städtisches Krankenhaus München-Bogenhausen
Englschalkinger Straße 77
81925 München
Phone: 089/92702061
Fax: 089/92702486
Email: Gastroenterologie@kh-bogenhausen.de
